
Shree Pacetronix (SHREEPAC) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
53.4M
Gross Profit
36.4M
68.11%
Operating Income
9.8M
18.43%
Net Income
6.6M
12.44%
EPS (Diluted)
₹1.85
Balance Sheet Metrics
Total Assets
230.5M
Total Liabilities
92.6M
Shareholders Equity
137.8M
Debt to Equity
0.67
Cash Flow Metrics
Revenue & Profitability Trend
Shree Pacetronix Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 168.0M | 220.4M | 202.6M | 92.3M | 75.6M |
Cost of Goods Sold | 55.4M | 82.0M | 75.4M | 36.1M | 30.3M |
Gross Profit | 112.7M | 138.4M | 127.2M | 56.2M | 45.3M |
Gross Margin % | 67.0% | 62.8% | 62.8% | 60.9% | 59.9% |
Operating Expenses | |||||
Research & Development | - | 6.9M | 6.7M | 2.3M | 2.3M |
Selling, General & Administrative | - | 26.0M | 23.1M | 9.8M | 9.3M |
Other Operating Expenses | 42.1M | 4.3M | 4.3M | 1.8M | 1.4M |
Total Operating Expenses | 42.1M | 37.2M | 34.1M | 13.9M | 13.1M |
Operating Income | 15.0M | 49.3M | 49.9M | 12.8M | 5.8M |
Operating Margin % | 8.9% | 22.4% | 24.6% | 13.9% | 7.7% |
Non-Operating Items | |||||
Interest Income | - | 668.1K | 700.8K | 451.8K | 305.9K |
Interest Expense | 5.8M | 3.6M | 2.5M | 2.8M | 3.3M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 10.4M | 46.2M | 46.2M | 10.6M | 1.3M |
Income Tax | 2.9M | 12.6M | 13.6M | 2.8M | 789.0K |
Effective Tax Rate % | 28.1% | 27.4% | 29.4% | 26.4% | 59.8% |
Net Income | 7.5M | 33.6M | 32.6M | 7.8M | 529.9K |
Net Margin % | 4.5% | 15.2% | 16.1% | 8.5% | 0.7% |
Key Metrics | |||||
EBITDA | 24.3M | 59.4M | 56.6M | 18.3M | 11.2M |
EPS (Basic) | ₹2.08 | ₹9.33 | ₹9.06 | ₹2.17 | ₹0.15 |
EPS (Diluted) | ₹2.08 | ₹9.33 | ₹9.06 | ₹2.17 | ₹0.15 |
Basic Shares Outstanding | 3605288 | 3599400 | 3599400 | 3599400 | 3599400 |
Diluted Shares Outstanding | 3605288 | 3599400 | 3599400 | 3599400 | 3599400 |
Income Statement Trend
Shree Pacetronix Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 2.5M | 1.1M | 712.5K | 8.9M | 7.7M |
Short-term Investments | 9.0M | 6.9M | 7.7M | 5.4M | 569.0K |
Accounts Receivable | 66.3M | 46.6M | 47.1M | 32.3M | 30.2M |
Inventory | 70.3M | 57.4M | 29.8M | 16.6M | 19.6M |
Other Current Assets | 23.3M | -1 | -1 | -1 | 3.7M |
Total Current Assets | 171.9M | 150.7M | 108.1M | 71.7M | 61.8M |
Non-Current Assets | |||||
Property, Plant & Equipment | 37.9M | 245.4K | 245.4K | 245.4K | 245.4K |
Goodwill | 836.0K | 840.0K | 844.2K | 893.7K | 900.1K |
Intangible Assets | 836.0K | 840.0K | 844.2K | 893.7K | 900.1K |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | - | - | - | - |
Total Non-Current Assets | 58.6M | 66.7M | 57.3M | 50.1M | 48.0M |
Total Assets | 230.5M | 217.5M | 165.4M | 121.8M | 109.8M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 8.7M | 2.5M | 6.1M | 1.5M | 3.5M |
Short-term Debt | 47.1M | 37.5M | 18.3M | 24.5M | 25.2M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 15.9M | 14.7M | 17.1M | 12.5M | -1 |
Total Current Liabilities | 88.7M | 81.3M | 64.7M | 51.4M | 46.3M |
Non-Current Liabilities | |||||
Long-term Debt | 3.6M | 5.4M | 3.6M | 5.9M | 6.8M |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | 4.0M | 5.8M | 3.9M | 6.2M | 7.2M |
Total Liabilities | 92.6M | 87.1M | 68.7M | 57.6M | 53.5M |
Equity | |||||
Common Stock | 36.0M | 36.0M | 36.0M | 36.0M | 36.0M |
Retained Earnings | - | 87.0M | 53.5M | 20.9M | 13.1M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 137.8M | 130.3M | 96.7M | 64.1M | 56.3M |
Key Metrics | |||||
Total Debt | 50.7M | 43.0M | 21.9M | 30.4M | 32.0M |
Working Capital | 83.2M | 69.4M | 43.3M | 20.3M | 15.5M |
Balance Sheet Composition
Shree Pacetronix Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 10.4M | 46.2M | 46.2M | 10.6M | 1.3M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -18.1M | -43.0M | -42.4M | -3.3M | 4.1M |
Operating Cash Flow | -2.5M | 6.2M | 5.5M | 9.7M | 8.6M |
Investing Activities | |||||
Capital Expenditures | -7.2M | -13.4M | -12.1M | -3.4M | -5.6M |
Acquisitions | - | - | - | - | - |
Investment Purchases | -1.7M | -4.8M | -441.4K | -3.5M | -119.1K |
Investment Sales | 5.0M | 803.0K | - | - | - |
Investing Cash Flow | -1.1M | -16.6M | -14.8M | -12.3M | -5.6M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | - | 1.9M | - | - | 719.8K |
Debt Repayment | -1.8M | - | -8.5M | -1.6M | -314.3K |
Financing Cash Flow | 7.7M | 21.1M | -14.8M | -2.2M | 91.2K |
Free Cash Flow | -7.2M | -14.1M | 4.6M | 13.5M | 3.3M |
Net Change in Cash | 4.1M | 10.7M | -24.1M | -4.8M | 3.1M |
Cash Flow Trend
Shree Pacetronix Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
70.45
Price to Book
5.33
Price to Sales
4.24
PEG Ratio
0.88
Profitability Ratios
Profit Margin
6.03%
Operating Margin
18.43%
Return on Equity
5.44%
Return on Assets
3.25%
Financial Health
Current Ratio
1.94
Debt to Equity
36.79
Beta
-1.61
Per Share Data
EPS (TTM)
₹2.89
Book Value per Share
₹38.18
Revenue per Share
₹48.04
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
shreepac | 747.4M | 70.45 | 5.33 | 5.44% | 6.03% | 36.79 |
Poly Medicure | 201.6B | 56.04 | 7.41 | 12.24% | 21.18% | 6.52 |
Dr Agarwal's Health | 138.9B | 137.59 | 7.50 | 4.33% | 5.66% | 49.87 |
Laxmi Dental | 19.9B | 71.39 | 7.89 | 15.22% | 9.53% | 9.35 |
Tarsons Products | 16.7B | 60.30 | 2.64 | 4.72% | 6.90% | 53.82 |
Prevest Denpro | 7.2B | 36.01 | 6.46 | 17.20% | 28.86% | 0.00 |
Financial data is updated regularly. All figures are in the company's reporting currency.